Latvia vs Netherlands: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Latvia
- Netherlands
How they compare
Netherlands currently reports 135 Cases against 46 Cases in Latvia, a difference of 89 Cases.
That makes Netherlands's figure about 2.9 times Latvia's.
Across all 20 years both countries report, Netherlands has been ahead every year.
Latvia ranks 4th and Netherlands ranks 2nd of 7 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 98.8 Cases | 315.4 Cases | 216.6 Cases | Netherlands |
| 2010s | 124.3 Cases | 249.5 Cases | 125.2 Cases | Netherlands |
| 2020s | 48.6 Cases | 154.6 Cases | 106 Cases | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Latvia or Netherlands?
- Netherlands, at 135 Cases against 46 Cases in Latvia as of 2024.
- What is the difference in communicable diseases — communicable disease incidence between Latvia and Netherlands?
- 89 Cases, with Netherlands ahead.
- How many years of comparable data are there for Latvia and Netherlands?
- 20 years are reported by both, from 2005 to 2024.
- How do Latvia and Netherlands rank globally for communicable diseases — communicable disease incidence?
- Latvia ranks 4th and Netherlands ranks 2nd of 7 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.